This chapter addresses SDGs 3 and 10 by addressing the disparities existing in mental healthcare in the US Latinx population.
This book chapter advances SDGs 3 and 10 by explaining how the acquisition of microbial communities during early life is closely intertwined with children’s immune and metabolic development. Environmental influences like prenatal maternal factors, delivery mode, peripartum antibiotic administration, nutrition, and the indoor microbiome in the hospital and home play a part during this critical early window.
This chapter addresses SDG 10 and SDG 3 by discussing the issues currently driving mental healthcare disparities in the Latinx population and how these approaches can provide a viable way to reduce them.
Elsevier,
Community Mental Health Engagement with Racially Diverse Populations, May 2020, Pages 49-82
This book chapter advances SDG 3 and 10 by outlining a community-based participatory research (CBPR) project where academic researchers and community organization leaders identify mental health and parenting needs through a needs assessment and panel discussion
Elsevier,
Community Mental Health Engagement with Racially Diverse Populations, May 2020, Pages 133-159
This book chapter advances SDG 3 and 10 by reviewing important considerations for working with Arab/Middle Eastern and North African (MENA) youth, including considerations of acculturation, discrimination, and cultural considerations regarding clinical care
Elsevier,
Community Mental Health Engagement with Racially Diverse Populations, May 2020, Pages 83-111
This book chapter advances SDG 3 and 10 by reviewing the health and mental health inequities of American Indian and Alaska Native (AI/AN) communities and how to overcome the disparities.
This chapter contributes to SDGs 2 and 3 by addressing topics associated with the alleviation of malnutrition in globally diverse populations via wheat and barley biofortification.
This book chapter advances SDG 3 by explaining how gene therapy, as an advanced therapy, is a promising strategy for treating musculoskeletal disorders through the delivery of therapeutic nucleic acids into the target cells.
This chapter addresses Goal 3 by examining late-life anxiety in older adults.
This chapter addresses Goal 3 by examining technology-based mental health services for the geriatric population.
